Goldman Sachs’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$960K Buy
212,751
+10,975
+5% +$49.5K ﹤0.01% 3871
2025
Q1
$894K Sell
201,776
-17,399
-8% -$77.1K ﹤0.01% 3881
2024
Q4
$1.72M Sell
219,175
-3,425
-2% -$26.8K ﹤0.01% 3579
2024
Q3
$2.93M Buy
222,600
+83,861
+60% +$1.1M ﹤0.01% 3107
2024
Q2
$1.68M Sell
138,739
-226,797
-62% -$2.74M ﹤0.01% 3291
2024
Q1
$5.94M Sell
365,536
-32,415
-8% -$527K ﹤0.01% 2439
2023
Q4
$2.71M Buy
397,951
+8,604
+2% +$58.7K ﹤0.01% 3011
2023
Q3
$2.12M Sell
389,347
-13,304
-3% -$72.5K ﹤0.01% 3060
2023
Q2
$2.73M Buy
402,651
+211,860
+111% +$1.44M ﹤0.01% 2999
2023
Q1
$956K Sell
190,791
-126,061
-40% -$632K ﹤0.01% 3686
2022
Q4
$1.55M Buy
316,852
+133,775
+73% +$653K ﹤0.01% 3433
2022
Q3
$2.64M Buy
183,077
+31,351
+21% +$452K ﹤0.01% 3149
2022
Q2
$2.3M Buy
151,726
+25,615
+20% +$388K ﹤0.01% 3331
2022
Q1
$1.5M Sell
126,111
-91,250
-42% -$1.08M ﹤0.01% 3796
2021
Q4
$3.52M Sell
217,361
-595,994
-73% -$9.66M ﹤0.01% 3080
2021
Q3
$23.2M Sell
813,355
-7,127
-0.9% -$203K ﹤0.01% 1630
2021
Q2
$27.7M Buy
820,482
+2,633
+0.3% +$89K 0.01% 1490
2021
Q1
$24.7M Sell
817,849
-43,589
-5% -$1.32M 0.01% 1538
2020
Q4
$42.7M Buy
861,438
+135,321
+19% +$6.7M 0.01% 1067
2020
Q3
$27.9M Buy
726,117
+146,239
+25% +$5.61M 0.01% 1262
2020
Q2
$25.1M Buy
579,878
+85,237
+17% +$3.68M 0.01% 1314
2020
Q1
$12.9M Sell
494,641
-82,205
-14% -$2.15M ﹤0.01% 1631
2019
Q4
$18M Buy
576,846
+314,390
+120% +$9.82M ﹤0.01% 1684
2019
Q3
$6.84M Buy
262,456
+36,589
+16% +$954K ﹤0.01% 2149
2019
Q2
$5.17M Buy
225,867
+1,102
+0.5% +$25.2K ﹤0.01% 2277
2019
Q1
$5.89M Sell
224,765
-13,013
-5% -$341K ﹤0.01% 2328
2018
Q4
$4.84M Sell
237,778
-73,432
-24% -$1.49M ﹤0.01% 2347
2018
Q3
$8.27M Buy
+311,210
New +$8.27M ﹤0.01% 2159